SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 8, Issue 2, Pages e000862
Publisher
BMJ
Online
2020-07-30
DOI
10.1136/jitc-2020-000862
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection
- (2020) Antonio Lalueza et al. CLINICAL MICROBIOLOGY AND INFECTION
- Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma
- (2020) Lorena Perez-Amill et al. HAEMATOLOGICA
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- On the use of corticosteroids for 2019-nCoV pneumonia
- (2020) Lianhan Shang et al. LANCET
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
- (2020) Nina Shah et al. LEUKEMIA
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics
- (2020) Jinnong Zhang et al. Lancet Respiratory Medicine
- Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data
- (2020) Gils Roex et al. Pharmaceutics
- Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic
- (2020) Veronika Bachanova et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Could ferritin help the screening for COVID-19 in hemodialysis patients?
- (2020) Stanislas Bataille et al. KIDNEY INTERNATIONAL
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- COVID-19 in patients with HIV: clinical case series
- (2020) Jose L Blanco et al. Lancet HIV
- Should cyclosporine be useful in renal transplant recipients affected by SARS‐CoV‐2?
- (2020) Beatriz Rodriguez‐Cubillo et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
- (2020) Luca Carsana et al. LANCET INFECTIOUS DISEASES
- Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma
- (2019) Jia Wei et al. Journal for ImmunoTherapy of Cancer
- Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates
- (2018) Koji Nakamura et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More